Related Products of 141452-01-9,Some common heterocyclic compound, 141452-01-9, name is Methyl indoline-5-carboxylate, molecular formula is C10H11NO2, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route.
Related Products of 141452-01-9,Some common heterocyclic compound, 141452-01-9, name is Methyl indoline-5-carboxylate, molecular formula is C10H11NO2, traditional synthetic route has been very mature, but the traditional synthetic route has various shortcomings, such as complicated route, low yield, poor purity, etc, below Introduce a new synthetic route.
(R)- l-(4-cyclopentyl- 1 ,3-dimethyl-2-oxo- 1 ,2,3,4-tetrahydropyrido [2,3-6] pyrazin-6- yl)indoline-5-carboxylic acid (i?)-6-chloro-4-cyclopentyl-l ,3-dimethyl-3,4-dihydropyrido[2,3-]pyrazin-2(lH)- one (42.0 mg, 0.15 mmol, 1 eq), methyl indoline-5-carboxylate (31.9 mg, 0.180 mmol, 1.2 eq), Pd2dba3 (6.9 mg, 0.0075 mmol, 5 mol%), XPhos (10.7 mg, 0.0225 mmol, 15 mol%) and K2C03 (82.9 mg, 0.60 mmol, 4 eq) were dissolved in tBuOH (1.5 mL, 0.1 M) and heated to 100 C for 20 hours. The mixture was filtered through celite, washed with DCM/EtOAc/MeOH and condensed. Purification by column chromatography (ISCO, 4 g silica column, 0-10%MeOH/DCM, 15 minute gradient) gave a mixture of the desired methyl ester and the (inconsequential) ethyl ester, which was used without further purification (65.56 mg). LCMS 40.48 (M+H), 435.47 (ethyl ester M+H). The resulting material was dissolved in THF (0.78 mL) and water (0.39 mL). LiOH (5.6 mg) was added and the mixture was stirred at room temperature. Due to poor solubility and sluggish conversion, an additional 5.6 mg LiOH, 0.39 mL water and 0.39 mL MeOH were added. After 2 days, the mixture was diluted with MeOH and purified by preparative HPLC to give a dark brown oil (33.84 mg, 0.08325 mmol, 53% over 2 steps. 1H NMR (400 MHz, Methanol-^) delta 8.11 (d, J= 8.6 Hz, 1H), 7.82 (dd, J= 8.6, 1.7 Hz, 1H), 7.76 (s, 1H), 7.23 – 7.16 (m, 1H), 6.24 (d, J= 8.5 Hz, 1H), 4.61 – 4.52 (m, 1H), 4.28 (q, J = 6.8 Hz, 1H), 4.06 (t, J= 8.8 Hz, 2H), 3.31 (s, 3H), 3.19 (t, J= 8.7 Hz, 2H), 2.09 (ddd, J = 17.1, 12.9, 8.7 Hz, 2H), 1.86 – 1.61 (m, 6H), 1.18 (d, J= 6.8 Hz, 3H). 13C NMR (100 MHz, cd3od) delta 169.88, 168.00, 150.16, 146.41, 132.06, 131.00, 126.64, 123.78, 121.72, 117.96, 112.26, 98.72, 58.11, 54.52, 50.70, 30.98, 30.72, 29.27, 27.49, 24.04, 23.33, 17.03. LCMS 407.48 (M+H).
These compound has a wide range of applications. It is believed that with the continuous development of the source of the synthetic route Methyl indoline-5-carboxylate, its application will become more common.
Reference:
Patent; DANA-FARBER CANCER INSTITUTE, INC.; BRADNER, James, E.; GRAY, Nathanael; QI, Jun; MCKEOWN, Michael, R.; BUCKLEY, Dennis; WO2015/117055; (2015); A1;,
Indoline – Wikipedia,
Indoline | C8H9N – PubChem